Latest Lintuzumab Stories
SAN FRANCISCO, Dec.
BERGEN, Norway, November 19, 2014 /PRNewswire/ -- BerGenBio AS, an oncology biopharmaceutical company, today announces that the US Food and Drug Administration (FDA) has
BERGEN, Norway, November 4, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that the first patient
- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - SEATTLE, Oct. 27, 2014 /PRNewswire/ -- CTI BioPharma Corp.
SEATTLE, June 12, 2014 /PRNewswire/ -- CTI BioPharma Corp.
Study Meets Pre-Specified CR/CRi Rate in First Nine Patients SAN DIEGO, June 10, 2014 /PRNewswire/ -- MEI Pharma, Inc.
Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising.
SAN DIEGO, Feb. 28, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the U.S.
Researchers at the Moffitt Cancer Center have discovered a control mechanism that can trigger the development of myelodysplastic syndromes (MDS), a group of blood cancers.
- The act of sweetening by admixture of some saccharine substance.